UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 10, 2013

 

 

AURORA DIAGNOSTICS HOLDINGS, LLC

(Exact name of registrant as specified in charter)

 

 

 

Delaware   333-176790   20-4918072

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

11025 RCA Center Drive, Suite 300, Palm Beach Gardens, Florida 33410

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (866) 420-5512

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 10, 2013, Gregory A. Marsh resigned as the Chief Financial Officer, Executive Vice President, Secretary and Treasurer of Aurora Diagnostics Holdings, LLC (the “Company”), effective as of June 5, 2013. On May 13, 2013, Michael Grattendick was appointed as the Vice President and Controller of the Company and, effective upon Mr. Marsh’s departure, will serve as the Company’s principal financial officer.

Mr. Grattendick, age 47, has served as the Director of Finance and Assistant Treasurer of the Company since 2006 and Director of Finance and Treasury since 2011.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      AURORA DIAGNOSTICS HOLDINGS, LLC

May 14, 2013

     

    /s/ Gregory A. Marsh

          Gregory A. Marsh
          Chief Financial Officer